Of note, myeloma-derived cells with enhanced NIK activity were shown to be sensitive to IKK2 inhibitors.22 Our study clarified that NIK depletes p100, while IKK2 induces pro-survival RelB:p50/NFκB response from IκBα-inhibited complex. The gene discussed is IKBKB; the disease is plasma cell myeloma.